Gatti M.; Pea F., Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 1271 - 1289 [articolo]Open Access
Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections, «ANTIBIOTICS», 2021, 10, Article number: 1311, pp. 1 - 12 [articolo]Open Access
Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems, «CLINICAL NUTRITION», 2021, 40, pp. 1176 - 1185 [articolo]
Filippini D.M.; Gatti M.; Di Martino V.; Cavalieri S.; Fusaroli M.; Ardizzoni A.; Raschi E.; Licitra L., Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis, «INTERNATIONAL JOURNAL OF CANCER», 2021, 149, pp. 675 - 683 [articolo]Open Access
Rinaldi M.; Bartoletti M.; Ferrarese A.; Franceschini E.; Campoli C.; Coladonato S.; Pascale R.; Tedeschi S.; Gatti M.; Cricca M.; Ambretti S.; Siniscalchi A.; Morelli M.C.; Cescon M.; Cillo U.; Di Benedetto F.; Burra P.; Mussini C.; Cristini F.; Lewis R.; Viale P.; Giannella M., Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study, «TRANSPLANT INFECTIOUS DISEASE», 2021, 23, Article number: e13608, pp. 1 - 9 [articolo]
Rinaldi M.; Bartoletti M.; Ferrarese A.; Franceschini E.; Campoli C.; Coladonato S.; Pascale R.; Tedeschi S.; Gatti M.; Cricca M.; Ambretti S.; Siniscalchi A.; Morelli M.C.; Cescon M.; Cillo U.; Di Benedetto F.; Burra P.; Mussini C.; Cristini F.; Lewis R.; Viale P.; Giannella M., Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study, «TRANSPLANT INFECTIOUS DISEASE», 2021, 23, Article number: e13608, pp. 1 - 9 [articolo]
Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access
Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access
Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio, Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2021, 76, pp. 199 - 205 [articolo]
Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [articolo]Open Access
Gatti, Milo; Pea, Federico, Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections, «CURRENT OPINION IN INFECTIOUS DISEASES», 2021, 34, pp. 737 - 747 [articolo]Open Access
Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707, pp. 1 - 11 [articolo]Open Access
Gatti M.; De Ponti F., Drug Interactions with Contraceptives, in: Trends in Andrology and Sexual Medicine, Berlino, Springer Science and Business Media Deutschland GmbH, 2021, pp. 325 - 359 (TRENDS IN ANDROLOGY AND SEXUAL MEDICINE) [capitolo di libro]
Gatti M.; De Ponti F., Drug repurposing in the covid-19 era: Insights from case studies showing pharmaceutical peculiarities, «PHARMACEUTICS», 2021, 13, Article number: 302, pp. 1 - 23 [articolo]Open Access
Donker E.; Brinkman D.; Richir M.; Papaioannidou P.; Likic R.; Sanz E.J.; Christiaens T.; Costa J.; De Ponti F.; Gatti M.; Bottiger Y.; Kramers C.; Garner S.; Pandit R.; Van Agtmael M.; Tichelaar J., European List of Essential Medicines for Medical Education: A protocol for a modified Delphi study, «BMJ OPEN», 2021, 11, Article number: e045635, pp. 1 - 4 [articolo]Open Access
